neuradex - NeuroDex Crunchbase Company Profile Funding Our arti excellent Tech Neurodex NeuroDex Company Profile 2024 Valuation Funding Investors PitchBook NeuroDex Alzheimers Drug Discovery Foundation NeuroDex is a developer of diagnostics theranostics prognostics and pharmacodynamic analysis in the neurology space The companys proprietary neuronderived exosome isolation technology can be applied across a number of neurological indications With the technology a simple blood draw could allow physicians and researchers to open a NeuroDexs preliminary data demonstrates strong identification of alphasynuclein the main component of Lewy bodies pathology in Parkinsons disease and Lewybody dementia and identification of TDP43 pathology in ALS NeuroDex intends to use the grant funds to further validate the method and reproduce the analysis in two larger cohorts NeuroDex General Information Description Developer a bloodbased diagnostics platform designed to diagnose neurodegenerative diseases The company has developed neurons oligodendrocytesderived and glialderived extracellular vesicles isolation technologies and technologies are used for the development of diagnostics with the leading indication being the diagnosis of alphasynuclein NeuroDex is developing a suite of bloodbased biomarkers that can identify patients with synucleinopathies even in the context of different forms of dementia This technology relies on NeuroDexs recent advances in isolating cellspecific extracellular vesicles exosomes from plasma and detecting protein markers of disease in the contents or on the surface of NDEs NeuroDex utilized the LuminEV technology to measure an array of synaptic proteins with the advantage that only one antibody against the synaptic protein is needed These measurements showed significant differences between early AD and healthy controls N60 MMSE20 and a significant correlation with cognitive scores Biomarker Discovery Services Neurodex About NeuroDex Inc NeuroDex is a biotechnology anggis devaki innovator dedicated to developing exosomeoforigin based diagnostics and prognostics Leveraging their proprietary ExoSORT technology NeuroDex aims to establish a suite of noninvasive diagnostics pushing the boundaries of bioinformatics and laboratory innovation Neurodex specializes in developing EVbased blood biomarkers to select patients and monitor treatment response in clinical trials We offer Biomarker Discovery Services for neurology using advanced EV technologies to deliver accurate and reliable results Our extensive expertise in targeted EV isolation and characterization combined with immunoassay validation and development enables high NeuroDex supports pharmaceutical companies in two main ways Theyve developed a biomarker product that aids drug discovery and another that offers a clinical biomarker to improve clinical trials Eitan explains that with NeuroDex clinical trials can be faster and more accurate because better biomarkers lead to more accurate population Home Page Neurodex NeuroDex is a biotech company focused on the diagnosis and treatment of neurodegenerative diseases through the development of bloodbased biomarker arrays Their core scientific approach centers on minimally invasive blood tests for the early detection of these debilitating conditions By isolating and analyzing neuronal exosomes from plasma they aim to develop a method for early and accurate NeuroDex Work in biotech NeuroDex Biotech Careers NeuroDex Products Competitors Financials Employees Headquarters NeuroDex is developing a suite of bloodbased biomarkers that can identify patients with synucleinopathies even in the context of different forms of dementia This technology relies on NeuroDexs recent advances in isolating cellspecific extracellular vesicles exosomes from plasma and detecting protein markers of disease in the contents or on the surface of NDEs Extracellular vesicles NeuroDex Pioneers New kode pos gebang raya periuk MultiPronged Biomarker for Neurodegenerative
ktki.kemkes.go
palantabo
